Skip to main content
Clinical Trials/CTRI/2018/02/011662
CTRI/2018/02/011662
Completed
Phase 4

To Compare The Efficacy And Safety Of Escitalopram & Vilazodone In Major Depressive Disorder

Government Medical College0 sites50 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Major Depressive Disorder
Sponsor
Government Medical College
Enrollment
50
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 14, 2016
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • newly diagnosed patients who meet the DSM 5 criteria for depression

Exclusion Criteria

  • (i) severe comorbid conditions like diabetes, hypertension \& ischemic heart disease (ii) patients taking antidepressans in the last 6 weeks (iii) pregnant or lactating females (iv) intake of other drugs for psychosis or anxiety (v) history of substance abuse (vi) any chronic ailment or drug intake leading to depression (vii)) patients with neurological disorders such as stroke, dementia or seizures.

Outcomes

Primary Outcomes

Not specified

Similar Trials